EI
Eikon Therapeutics, Inc. Common Stock (EIKN)
NASDAQ·Healthcare·Biotechnology
$5.50
-1.89%
Mkt Cap $393.05M
Analyst Ratings
Buy
0
Hold
0
Sell
2
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
-9.1%
Consensus $5.00 vs current $5.50